Business Context and Reporting Period
This Form 8-K filing by Landec Corporation (not Lifecore Biomedical, Inc.) reports on the results of its 2021 Annual Meeting of Stockholders held on October 20, 2021. The filing covers the voting outcomes for three proposals presented to stockholders as of the record date of August 23, 2021, when 29,461,710 shares of Common Stock were outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
The following material events were reported regarding the Annual Meeting:
- Election of Directors: All five nominees were elected to the Board of Directors for a two-year term.
- Deborah Carosella received the highest support with 21,334,410 votes for.
- Albert D. Bolles, Ph.D. received the lowest support among nominees with 16,819,179 votes for.
- Total broker non-votes were 3,041,387 for all director elections.
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending May 29, 2022.
- Votes For: 25,138,609
- Votes Against: 14,589
- Abstain: 406
- Executive Compensation Advisory Vote: Stockholders approved the non-binding advisory proposal on executive compensation.
- Votes For: 20,155,216
- Votes Against: 1,465,183
- Abstain: 491,818
- Broker Non-Votes: 3,041,387
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Important Facts for Investors to Verify
- Verify the discrepancy between the requested company name (Lifecore Biomedical, Inc.) and the actual registrant in the filing (Landec Corporation).
- Confirm the composition of the newly elected Board of Directors and their respective terms.
- Note the significant number of broker non-votes (3,041,387) which did not impact the outcome of the director elections but indicates a portion of shares held in street name.
- Review the "Against" vote count for the executive compensation proposal (1,465,183) to assess shareholder sentiment regarding pay practices.